✦ LIBER ✦

Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

✍ Scribed by Sztanek, F.; Seres, I.; Harangi, M.; Locsey, L.; Padra, J.; Paragh, G. J. R.; Asztalos, L.; Paragh, G.

Book ID: 119969215
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 194 KB
Volume: 27
Category: Article
ISSN: 0931-0509
DOI: 10.1093/ndt/gfr753

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum paraoxonase 1 (PON1) lactonase act

Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis

✍ Gugliucci, Alejandro; Kinugasa, Eriko; Kotani, Kazuhiko; Caccavello, Russell; Ki 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 204 KB

Serum paraoxonase 1 (PON1) lactonase act

Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis

✍ Gugliucci, Alejandro; Kinugasa, Eriko; Kotani, Kazuhiko; Caccavello, Russell; Ki 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 204 KB

## Abstract **Background:** The mechanism of paraoxonase 1 (PON1) atheroprotective remains elusive. The lactonizing/lactonase activity of PON1 is gaining favor as the most significant in physiology. **Methods:** We studied 42 end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and

LIPOPROTEIN PROFILE, HSCRP AND SERUM PAR

LIPOPROTEIN PROFILE, HSCRP AND SERUM PARAOXONASE ACTIVITY IN END-STAGE RENAL DISEASE PATIENTS ON LONG-TERM HAEMODIALYSIS

✍ Lahrach, H.; Taki, H.; Kettani, A.; Ghalim, N.; Ramdani, B.; Saile, R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Cardiovascular risk and mortality in end

Cardiovascular risk and mortality in end-stage renal disease patients undergoing dialysis: sleep study, pulmonary function, respiratory mechanics, upper airway collapsibility, autonomic nervous activity, depression, anxiety, stress and quality of life: a prospective, double blind, randomized controlled clinical trial

✍ dos Reis Santos, Israel; Danaga, Aline; de Carvalho Aguiar, Isabella; Oliveira, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 562 KB